You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PCI-24781

Showing 1 - 25 of 1,671
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Metastatic Solid Tumors Trial in San Francisco (PZP115891, PCI-24781)

Recruiting
  • Metastatic Solid Tumors
  • PZP115891, PCI-24781
  • San Francisco, California
    University of California, San Francisco
Aug 23, 2021

Renal Cell Carcinoma Trial in Worldwide (Pazopanib, Abexinostat, Placebo)

Recruiting
  • Renal Cell Carcinoma
  • Phoenix, Arizona
  • +37 more
May 10, 2021

Coronary Artery Disease Trial in Ho Chi Minh City (Percutaneous Coronary Intervention)

Recruiting
  • Coronary Artery Disease
  • Percutaneous Coronary Intervention
  • Ho Chi Minh City, Vietnam
    University Medical Center
Oct 1, 2023

ST Elevation Myocardial Infarction Trial in Isehara (Percutaneous coronary intervention)

Enrolling by invitation
  • ST Elevation Myocardial Infarction
  • Percutaneous coronary intervention
  • Isehara, Kanagawa, Japan
    Tokai University Hospital
Nov 21, 2022

International Post-PCI FFR Extended Registry

Completed
  • Coronary Disease
  • Percutaneous coronary intervention
  • Seoul, Korea, Republic of
    Bon-Kwon Koo
Jan 28, 2023

Percutaneous Coronary Intervention Optimization With Fractional

Completed
  • Coronary Artery Disease
  • +2 more
  • IVUS guided PCI optimization
  • +2 more
  • (no location specified)
Feb 19, 2023

Complex Coronary Lesions Trial in Worldwide (IVUS, Angio)

Recruiting
  • Complex Coronary Lesions
  • IVUS
  • Angio
  • Aalst, Belgium
  • +31 more
Nov 24, 2022

Coronary Disease, Coronary Artery Disease, Coronary Restenosis Trial in Lucerne (Impact of current PCI techniques/ devices in

Recruiting
  • Coronary Disease
  • +9 more
  • Impact of current PCI techniques/ devices in complex coronary artery lesions
  • Lucerne, Switzerland
    Lucerne Heart Centre
Oct 4, 2023

Coronary Artery Disease Trial in Sacramento (device, behavioral, other)

Recruiting
  • Coronary Artery Disease
  • LiveCare
  • +2 more
  • Sacramento, California
    University of California, Davis Medical Center Division of Cardi
Oct 27, 2023

Coronary Artery Disease Trial in Ferrara, Naples (Cangrelor 50 MG)

Not yet recruiting
  • Coronary Artery Disease
  • Cangrelor 50 MG
  • Ferrara, Italy
  • +1 more
Oct 13, 2023

Identify Patients Undergoing Elective PCI at Risk of Peri-PCI

Recruiting
  • Coronary Artery Disease
  • Assessment of platelet reactivity
  • Troponin measurement
  • Jacksonville, Florida
    University of Florida Jacksonville
Nov 15, 2022

Coronary Artery Disease Left Main, Coronary Artery Disease Trial in Seoul (FFR-Guided PCI, Angiography-Guided PCI)

Not yet recruiting
  • Coronary Artery Disease Left Main
  • Coronary Artery Disease
  • FFR-Guided PCI
  • Angiography-Guided PCI
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Apr 28, 2023

Coronary Microvascular Dysfunction Trial in Beijing (Bivalirudin, standard heparin)

Active, not recruiting
  • Coronary Microvascular Dysfunction
  • Beijing, Beijing, China
    Peking university first hospital
Aug 1, 2023

Ischemic Heart Disease Trial in Seoul (Percutaneous coronary intervention)

Completed
  • Ischemic Heart Disease
  • Percutaneous coronary intervention
  • Seoul, Korea, Republic of
    Samsung Medical Center
Oct 24, 2022

Non-ST-elevation Myocardial Infarction, Multivessel Coronary Artery Disease Trial in Leipzig (Culprit-lesion revascularization,

Not yet recruiting
  • Non-ST-elevation Myocardial Infarction
  • Multivessel Coronary Artery Disease
  • Culprit-lesion revascularization
  • Non-culprit-lesion revascularization
  • Leipzig, Germany
    Heart Center Leipzig at University of Leipzig, Department of Int
Mar 27, 2023

STEMI - ST Elevation Myocardial Infarction, Myocardial Infarction, Acute Coronary Syndrome Trial in Mexico City (percutaneous

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
  • +2 more
  • percutaneous coronary intervention (PCI)
  • Mexico City, Mexico
    Instituto Nacional de Cardiología Ignacio Chávez
Aug 22, 2023

Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Cona, Latina (Microcatheter-derived FFR,

Recruiting
  • Coronary Artery Disease
  • Percutaneous Coronary Intervention
  • Microcatheter-derived FFR
  • +2 more
  • Cona, Ferrara, Italy
  • +1 more
Dec 23, 2022

ST Elevation Myocardial Infarction Trial in Bucheon (Repatha®)

Recruiting
  • ST Elevation Myocardial Infarction
  • Bucheon, Korea, Republic of
    Sejong General Hospital
Oct 10, 2023

Percutaneous Coronary Intervention Trial in Seoul

Not yet recruiting
  • Percutaneous Coronary Intervention
    • Seoul, Korea, Republic of
    • +1 more
    Aug 1, 2023

    STEMI, Multi Vessel Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Xiamen (In-hospital staged PCI,

    Recruiting
    • STEMI
    • +2 more
    • In-hospital staged PCI
    • Out-hospital staged PCI
    • Xiamen, Fujian, China
      Xiamen Cardiovascular Hospital Xiamen University
    Oct 29, 2022

    Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)

    Recruiting
    • Acute Coronary Syndrome
    • CYP2C19 Polymorphism
    • Nieuwegein, Utrecht, Netherlands
      St. Antonius Hospital
    Jun 27, 2023

    Acute Myocardial Infarction Trial in Beijing (Middle Dose, High Dose, Placebo)

    Completed
    • Acute Myocardial Infarction
    • Middle Dose
    • +2 more
    • Beijing, China
      Fuwai Hospital, Chinese Academy of Medical Sciences
    Jul 31, 2023

    Patients With Acute Coronary Syndrome

    Recruiting
    • Coronary Syndrome
    • blood draws
    • Milano, Milan, Italy
      IRCCS Policlinico S. Donato, Milan, Italy
    Oct 4, 2023

    Cardiovascular Diseases, Percutaneous Coronary Intervention Trial in Hamilton (Higher Dose UFH, Lower Dose UFH)

    Recruiting
    • Cardiovascular Diseases
    • Percutaneous Coronary Intervention
    • Higher Dose UFH
    • Lower Dose UFH
    • Hamilton, Ontario, Canada
      Hamilton Health Sciences, General Hospital
    Sep 19, 2022